0

Journal Articles

in Percutaneous Coronary Intervention
 41-60 of 80 Articles
Editorial |  January 03, 2007
Pexelizumab Does Not “Complement” Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction
John W. Eikelboom, MBBS; Martin O’Donnell, MB
JAMA. 2007;297(1):91-92. doi:10.1001/jama.297.1.91.
Original Contribution |  January 03, 2007 FREE
Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention:  A Randomized Controlled Trial
JAMA. 2007;297(1):43-51. doi:10.1001/jama.297.1.43.
Original Contribution |  October 25, 2006 FREE
Disparities in the Utilization of High-Volume Hospitals for Complex Surgery
Jerome H. Liu, MD, MSHS; David S. Zingmond, MD, PhD; Marcia L. McGory, MD; et al.
JAMA. 2006;296(16):1973-1980. doi:10.1001/jama.296.16.1973.
Original Contribution |  October 11, 2006 FREE
Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction
Ulf Stenestrand, MD, PhD; Johan Lindbäck, MSc; Lars Wallentin, MD, PhD; et al.
JAMA. 2006;296(14):1749-1756. doi:10.1001/jama.296.14.1749.
Editorial |  April 05, 2006
Clopidogrel Treatment Prior to Percutaneous Coronary Intervention:  When Enough Isn't Enough
Steven R. Steinhubl, MD; Richard Charnigo, PhD
JAMA. 2006;295(13):1581-1582. doi:10.1001/jama.295.13.jed60017.
Original Contribution |  April 05, 2006 FREE
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment:  The ISAR-REACT 2 Randomized Trial
Adnan Kastrati, MD; Julinda Mehilli, MD; Franz-Josef Neumann, MD; et al.
JAMA. 2006;295(13):1531-1538. doi:10.1001/jama.295.13.joc60034.
Editorial |  September 14, 2005
Paclitaxel-Eluting Stents in Complex Lesions
Antonio Colombo, MD; John Cosgrave, MD
JAMA. 2005;294(10):1268-1270. doi:10.1001/jama.294.10.1268.
Original Contribution |  September 14, 2005 FREE
Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics:  The PCI-CLARITY Study
Marc S. Sabatine, MD, MPH; Christopher P. Cannon, MD; C. Michael Gibson, MD, MS; et al.
JAMA. 2005;294(10):1224-1232. doi:10.1001/jama.294.10.1224.
Original Contribution |  August 17, 2005 FREE
Relationship Between Time of Day, Day of Week, Timeliness of Reperfusion, and In-Hospital Mortality for Patients With Acute ST-Segment Elevation Myocardial Infarction
David J. Magid, MD, MPH; Yongfei Wang, MS; Jeph Herrin, PhD; et al.
JAMA. 2005;294(7):803-812. doi:10.1001/jama.294.7.803.
Original Contribution |  July 27, 2005 FREE
Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
Anvar Babaev, MD, PhD; Paul D. Frederick, MPH, MBA; David J. Pasta, MS; et al.
JAMA. 2005;294(4):448-454. doi:10.1001/jama.294.4.448.
Editorial |  June 15, 2005
To Cath or Not to Cath:  That Is No Longer the Question
Deepak L. Bhatt, MD
JAMA. 2005;293(23):2935-2937. doi:10.1001/jama.293.23.2935.
Editorial |  June 15, 2005
Acute PCI for ST-Segment Elevation Myocardial Infarction:  Is Later Better Than Never?
Raymond J. Gibbons, MD; Cindy L. Grines, MD
JAMA. 2005;293(23):2930-2932. doi:10.1001/jama.293.23.2930.
Clinical Review |  March 23, 2005 FREE
Diabetes and Coronary Revascularization
James D. Flaherty, MD; Charles J. Davidson, MD
JAMA. 2005;293(12):1501-1508. doi:10.1001/jama.293.12.1501.
INCLUDES: CME
Commentary |  March 16, 2005
Regionalization of Care for Acute Coronary Syndromes:  More Evidence Is Needed
Saif S. Rathore, MPH; Andrew J. Epstein, PhD, MPP; Kevin G. M. Volpp, MD, PhD; et al.
JAMA. 2005;293(11):1383-1387. doi:10.1001/jama.293.11.1383.
Original Contribution |  March 02, 2005 FREE
Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction:  A Randomized Controlled Trial
Gregg W. Stone, MD; John Webb, MD; David A. Cox, MD; et al.
JAMA. 2005;293(9):1063-1072. doi:10.1001/jama.293.9.1063.
Special Communication |  February 23, 2005
Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction:  Is the Slope of the Curve the Shape of the Future?
Bernard J. Gersh, MB, ChB, FRCP; Gregg W. Stone, MD; Harvey D. White, DSc; et al.
JAMA. 2005;293(8):979-986. doi:10.1001/jama.293.8.979.
Editorial |  October 27, 2004
Is Onsite Surgery Backup Necessary for Percutaneous Coronary Interventions?
W. Douglas Weaver, MD
JAMA. 2004;292(16):2014-2016. doi:10.1001/jama.292.16.2014.
Original Contribution |  October 27, 2004 FREE
Outcomes of Percutaneous Coronary Interventions Performed at Centers Without and With Onsite Coronary Artery Bypass Graft Surgery
David E. Wennberg, MD, MPH; F. Lee Lucas, PhD; Andrea E. Siewers, MPH; et al.
JAMA. 2004;292(16):1961-1968. doi:10.1001/jama.292.16.1961.
Original Contribution |  October 13, 2004 FREE
Regionalization of Percutaneous Transluminal Coronary Angioplasty and Implications for Patient Travel Distance
Susan M. Kansagra, BS; Lesley H. Curtis, PhD; Kevin A. Schulman, MD
JAMA. 2004;292(14):1717-1723. doi:10.1001/jama.292.14.1717.
Editorial |  October 06, 2004
Measuring Race and Ethnicity: Why and How?
Margaret A. Winker, MD
JAMA. 2004;292(13):1612-1614. doi:10.1001/jama.292.13.1612.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  Oct 2012
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy
Olivier Turrini, MD; Eric Lambaudie, MD; Marion Faucher, MD; et al.
JAMA Internal Medicine
Invited Commentary  |  Aug 13/27, 2012
How Drug-Eluting Stents Illustrate Our Health System's Flawed Relationship With Technology:  Comment on “Use of Drug-Eluting Stents as a Function of Predicted Benefit”
Peter W. Groeneveld, MD, MS
JAMA Internal Medicine
Original Investigation  |  Aug 13/27, 2012
Use of Drug-Eluting Stents as a Function of Predicted Benefit:  Clinical and Economic Implications of Current Practice
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
JAMA Internal Medicine
Editor's Correspondence  |  July 9, 2012
Percutaneous Coronary Intervention for Stable Coronary Artery Disease: The Debate Continues
Elvis A. Peter, MD; Nuri I. Akkus, MD; Jai Varma, MD, FSCAI
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems